Special Issue "Personalized Medicine and Management of COVID-19"
Deadline for manuscript submissions: 25 April 2023 | Viewed by 36971
Interests: cancer; bone; genomics; genetics; immunology
Interests: medicine; public health; environmental health/ecology; one health; pharmacy; pharmacology; sustainability; clinical trials; experimental studies
Special Issues, Collections and Topics in MDPI journals
COVID-19 poses a major global threat to humankind, inflicting devastating consequences as to public health. Its effect has shown racial, age and sex differences. Understanding its pathological and epidemiological variation along with providing a personalized treatment will greatly reduce its damage and enhance the preparedness for a future pandemic caused by either COVID-19 or other infectious diseases.
This Special Issue focusses on the personalization of epidemics, disease characterization, treatment and management of COVID-19, with a special emphasis on countries, regions, sex, aging groups and racial differences.
While an abundance of literature on COVID-19 has accumulated, detailed personalized analysis remains incompletely explored. As the pandemic has so far lasted a year and half, studies with solid experimental and a considerable amount of data, particularly on molecular mechanisms and overall genetics, will provide valuable information for both the general public and the scientific community.
We are looking for papers that provide a novel contribution to optimize the personalization of medicine covering all aspects of COVID-19. For example, we welcome papers related to personalized and sex difference in pathological classification, diagnosis, treatment, recovering process, and COVID-19-related sequelae along with the variations in disease epidemiological patterns, transmission and management according to countries, regions, sex and races.
Prof. Dr. Weikuan Gu
Prof. Dr. Lotfi Aleya
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.